Rubius Therapeutics, Inc.

MUN:5RT Stock Report

Market Cap: €1.4m

Rubius Therapeutics Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Craig Jalbert

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenure2.4yrs

Recent management updates

Recent updates

CEO

Craig Jalbert (61 yo)

less than a year

Tenure

Mr. Craig R. Jalbert, CIRA serves as Director at Oncorus, Inc. since July 28, 2023 and serves as Chief Executive Officer, President, Chief Financial Officer, Treasurer and Secretary from August 4, 2023. He...

Board Members

NamePositionTenureCompensationOwnership
Craig Jalbert
Presidentless than a yearno datano data
Michael Rosenblatt
Independent Director8.8yrsUS$421.66kno data
Robert Langer
Member of Scientific Advisory Board8.8yrsUS$850.74kno data
Harvey Lodish
Scientific Advisory Board5.7yrsUS$24.00kno data
Gerald Nepom
Member of Scientific Advisory Board2.4yrsno datano data
Vijay Kuchroo
Member of Scientific Advisory Board2.4yrsno datano data
Susanne Schaffert
Director1.3yrsno datano data
Francis Cuss
Independent Director5.8yrsUS$426.66kno data
Christopher Carpenter
Member of Scientific Advisory Board3.8yrsUS$2.84mno data
Christopher Hunter
Member of Scientific Advisory Board2.4yrsno datano data
John Monroe
Member of Scientific Advisory Board2.4yrsno datano data

2.4yrs

Average Tenure

68yo

Average Age

Experienced Board: 5RT's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.